Basit öğe kaydını göster

dc.contributor.authorKayserili Karabay, Hülya
dc.contributor.authorToksoy, Güven
dc.contributor.authorBokhoven, H Van
dc.contributor.authorBaşaran, Seher
dc.contributor.authorUyguner, Zehra Oya
dc.contributor.authorÖzgür, Hilal
dc.contributor.authorAltunoğlu, Umut
dc.date.accessioned2021-03-04T19:25:18Z
dc.date.available2021-03-04T19:25:18Z
dc.identifier.citationUyguner Z. O. , Özgür H., Altunoğlu U., Toksoy G., Başaran S., Bokhoven H. V. , Kayserili Karabay H., "Is Arg5 in HOXDNA binding domain of HOXB1 hot spot for congenital facial paralysis mimicking Moebius syndrome? ", European Human Genetics Conference 2013, Paris, Fransa, 8 - 11 Haziran 2013, cilt.21, no.1, ss.98
dc.identifier.othervv_1032021
dc.identifier.otherav_8fb0ed9d-f317-4420-b658-fe1b590ae66d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/97020
dc.description.abstractCongenital facial paralysis (CFP) and Moebius syndrome (MBS; MIM157900) are highly sporadic, formulating classical gene identi􀏐ication algorithmsdif􀏐icult, assigning candidate gene approach compatible. Mutantmice for Hoxb1 were long before reported to present features of facial nervedefects, resembling MBS, only very recently associated with human phenotype.Currently, homozygous c.619C>T in HOXB1 revealed in the two CFPaffected individuals from two different families, both from the same geographicorigin, altering arginine to cysteine at 207 (p.arg207cys) correspondsarg5 residue of the HOXB1 homeodomain.We have screened our cohort of 33 sporadic MBS and CFP patients for mutationon HOXB1 and identi􀏐ied homozygous c.620G>A in one consanguineousfamily. Alteration changes the same neutral-polar arginine, via second nucleotide,resulting to basic-polar histidine (p.arg207his). Clinical investigationof our case presented left esotropia, right 􀏐lattened/broad nasal bridge,external ear defects, high arched palate, bilateral cranial nerve VII dysfunction,diagnosed as CFP. We further screened HOXB1 in 56 DNA samples ofMBS cases, referred to us from Radbound University Nijmegen-Holland,none found to carry any pathological alteration. It is surprising that, such arare disorder with three only identi􀏐ied mutation striking the same conservedamino acid, delegating arg5 the achilles of HOXB1 protein. Up to date,out of 267 families with MBS or with the facial weakness, component ofMBS (177 from Webb et al.2012, 56 from Nijmegan group and 34 from ourcenter), only three reported to carry mutations in HOXB1 gene, 􀏐iguring theprevalence of HOXB1 mutation frequency to be 1.12%.
dc.language.isoeng
dc.subjectPEDİATRİ
dc.subjectGENETİK VE HAYAT
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectPediatrik Nöroloji
dc.subjectTıbbi Genetik
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectKlinik Tıp
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectKlinik Tıp (MED)
dc.subjectTIP, GENEL & İÇECEK
dc.titleIs Arg5 in HOXDNA binding domain of HOXB1 hot spot for congenital facial paralysis mimicking Moebius syndrome?
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume21
dc.contributor.firstauthorID1041282


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster